TA-01 is a potent inhibitor of CK1δ/ε and p38 MAPK, with IC50 of 6.4 nM, 6.8 nM and 6.7 nM for CK1ε, CK1δ and p38 MAPK, respectively.

 

Brand: BCM

 

Signaling Pathways: MAPK; Metabolism; Stem Cells; Autophagy

 

Boiling Point: 511.1±50.0 °C(Predicted)

 

pKa: 9.26±0.24(Predicted)

 

GHS: GHS07

 

Solubility: Soluble in DMSP; soluble in Ethanol. Insoluble in Water.

 

Isomeric SMILES: C1=CC(=C(C(=C1)F)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)F  

 

InChIKey: TWPJJJZCYVFUOA-UHFFFAOYSA-N  

 

InChI: InChI=1S/C20H12F3N3/c21-14-6-4-12(5-7-14)18-19(13-8-10-24-11-9-13)26-20(25-18)17-15(22)2-1-3-16(17)23/h1-11H,(H,25,26)

 

Attribute
[Chem Name]	4-[2-(2,6-difluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine
[Synonym]	TA-01; TA01; TA 01
[CAS No.]	1784751-18-3
[MDL No.]	MFCD30182287
[Formula]	C20H12F3N3
[Molecular]	351.32
[Form]	A crystalline solid
[Storage]	Keep in dark place. Inert atmosphere. Room temperature

Goods Tag